Processa Pharmaceuticals logo
Processa Pharmaceuticals PCSA
€ 1.45 -4.22%
report update icon

Quartalsbericht 2026-Q3
hinzugefügt 13.11.2026

Processa Pharmaceuticals Langfristige Verbindlichkeiten | PCSA

Langfristige Verbindlichkeiten Jährlich Processa Pharmaceuticals

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- 487 66.9 K 151 K 7.38 K 1.05 M 1.68 M 2.87 M 9.96 K - - 494 K 145 K 606 K 2.2 M

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
2.87 M 487 773 K

Langfristige Verbindlichkeiten Vierteljährlich Processa Pharmaceuticals

2026-Q1 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - - - 487 2.17 K 25.6 K - 66.9 K 88.8 K 109 K 129 K 151 K 172 K 4.66 K 6.15 K 7.38 K 591 K 735 K 906 K 1.05 M - 1.52 M 1.53 M 1.68 M 1.86 M 2.02 M 2.23 M 2.13 M 2.27 M 2.48 M - 9.96 K - - - - - - - 494 K 27.5 K 105 K 119 K 494 K 494 K 494 K 494 K 145 K 145 K 145 K 145 K 606 K 606 K 606 K - - - - -

Alle Zahlen in USD-Währung

Indikatorspanne aus vierteljährlicher Berichterstattung

Höchstwert Mindestwert Durchschnitt
2.48 M 487 656 K

Langfristige Verbindlichkeiten anderer Aktien in der Pharmaeinzelhändler

Name Langfristige Verbindlichkeiten Preis % 24h Marktkapitalisierung Land
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCC
2 K - -5.98 % $ 34.1 M usaUSA
Diffusion Pharmaceuticals Diffusion Pharmaceuticals
DFFN
480 K - 11.68 % $ 8.97 M usaUSA
Eloxx Pharmaceuticals Eloxx Pharmaceuticals
ELOX
5.24 M - -5.68 % $ 8.28 M usaUSA
Enochian Biosciences Enochian Biosciences
ENOB
56.2 K - - $ 40.5 M usaUSA
Esperion Therapeutics Esperion Therapeutics
ESPR
355 M - - $ 661 M usaUSA
Evofem Biosciences Evofem Biosciences
EVFM
4.89 M - 7.55 % $ 38.1 M usaUSA
Eyenovia Eyenovia
EYEN
8 M - 49.81 % $ 13.2 M usaUSA
FibroGen FibroGen
FGEN
85.9 M - - $ 889 M usaUSA
Homology Medicines Homology Medicines
FIXX
8.42 M - 0.77 % $ 53.4 M usaUSA
Amicus Therapeutics Amicus Therapeutics
FOLD
245 M - - $ 4.47 B usaUSA
Frequency Therapeutics Frequency Therapeutics
FREQ
50.1 M - - $ 528 M usaUSA
Galecto Galecto
GLTO
81 K - - $ 762 M danmarkDanmark
GlycoMimetics GlycoMimetics
GLYC
1.21 M - 9357.83 % $ 1.01 B usaUSA
Graybug Vision Graybug Vision
GRAY
16.4 M - -11.23 % $ 9.65 M usaUSA
Galera Therapeutics Galera Therapeutics
GRTX
152 M - -32.59 % $ 7.61 M usaUSA
Happiness Biotech Group Limited Happiness Biotech Group Limited
HAPP
1.38 M - 1.35 % $ 17.8 M chinaChina
Novavax Novavax
NVAX
844 M $ 7.47 -3.24 % $ 1.21 B usaUSA
Hepion Pharmaceuticals Hepion Pharmaceuticals
HEPA
103 K - -18.79 % $ 39.3 K usaUSA
Hoth Therapeutics Hoth Therapeutics
HOTH
2.71 K - - $ 18.8 M usaUSA
IMARA IMARA
IMRA
67 K - 15.96 % $ 663 M usaUSA
KalVista Pharmaceuticals KalVista Pharmaceuticals
KALV
110 M - - $ 1.45 B britainBritain
KemPharm KemPharm
KMPH
90.8 M - -0.34 % $ 200 M usaUSA
Kezar Life Sciences Kezar Life Sciences
KZR
5.46 M - - $ 53.3 M usaUSA
Lixte Biotechnology Holdings Lixte Biotechnology Holdings
LIXT
439 K - - $ 63.4 M usaUSA
Magenta Therapeutics Magenta Therapeutics
MGTA
6.79 M - -7.74 % $ 41.6 M usaUSA
NovaBay Pharmaceuticals NovaBay Pharmaceuticals
NBY
639 M - - $ 11.3 M usaUSA
NeuroBo Pharmaceuticals NeuroBo Pharmaceuticals
NRBO
142 K - 0.43 % $ 12 M usaUSA
OncoCyte Corporation OncoCyte Corporation
OCX
45.1 M - 17.22 % $ 355 K usaUSA
Onconova Therapeutics Onconova Therapeutics
ONTX
100 K - -0.47 % $ 21 M usaUSA
Opthea Limited Opthea Limited
OPT
201 M - - $ 1.2 B australiaAustralia
Verastem Verastem
VSTM
117 M $ 6.33 -7.8 % $ 439 M usaUSA
BiomX BiomX
PHGE
706 K $ 1.85 14.2 % $ 3.02 M israelIsrael
Pieris Pharmaceuticals Pieris Pharmaceuticals
PIRS
20.2 M - -15.58 % $ 1.22 B germanyGermany
Plus Therapeutics Plus Therapeutics
PSTV
15 K - - $ 301 M usaUSA
Pluristem Therapeutics Pluristem Therapeutics
PSTI
9.59 M - -1.9 % $ 33.3 M israelIsrael
Qualigen Therapeutics Qualigen Therapeutics
QLGN
1.71 M - 5.59 % $ 1.16 M usaUSA
Qilian International Holding Group Limited Qilian International Holding Group Limited
QLI
1.33 M - -6.08 % $ 184 M chinaChina
Cassava Sciences Cassava Sciences
SAVA
118 K - - $ 110 M usaUSA
Selecta Biosciences Selecta Biosciences
SELB
408 M - -8.69 % $ 126 M usaUSA
Sangamo Therapeutics Sangamo Therapeutics
SGMO
298 M - - $ 50.4 M usaUSA
Salarius Pharmaceuticals Salarius Pharmaceuticals
SLRX
39.2 K - - $ 2.64 M usaUSA
Sensei Biotherapeutics Sensei Biotherapeutics
SNSE
59 K - - $ 17.5 M usaUSA
Sonnet BioTherapeutics Holdings Sonnet BioTherapeutics Holdings
SONN
46.6 K - - $ 826 K usaUSA
Synthetic Biologics Synthetic Biologics
SYN
12.8 M - 1.32 % $ 16.2 M usaUSA
Synlogic Synlogic
SYBX
12.5 M - - $ 7.07 M usaUSA
Virios Therapeutics, LLC Virios Therapeutics, LLC
VIRI
12.2 M - 2710.01 % $ 72.9 M usaUSA
Vallon Pharmaceuticals Vallon Pharmaceuticals
VLON
15 K - -6.47 % $ 5.76 M usaUSA
Vaxart Vaxart
VXRT
9.1 M - -25.06 % $ 46.3 M usaUSA
XOMA Corporation XOMA Corporation
XOMA
134 M - - $ 485 M usaUSA
Repare Therapeutics Repare Therapeutics
RPTX
59.2 M - - $ 112 M canadaCanada